Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines
暂无分享,去创建一个
G. Maurer | J. Breuss | V. Zilberfarb | P. Uhrin | P. Hohensinner | S. Pfaffenberger | S. Demyanets | K. Huber | K. Rychli | A. Furnkranz | J. Zaujec
[1] P. Sucharda,et al. Angiogenic factors are elevated in overweight and obese individuals , 2005, International Journal of Obesity.
[2] K. Yagui,et al. Roles of degree of fat deposition and its localization on VEGF expression in adipocytes. , 2005, American journal of physiology. Endocrinology and metabolism.
[3] E. Silverman,et al. Oncostatin M causes VEGF release from human airway smooth muscle: synergy with IL-1beta. , 2005, American journal of physiology. Lung cellular and molecular physiology.
[4] G. Maurer,et al. Inflammatory Cytokines Interleukin-6 and Oncostatin M Induce Plasminogen Activator Inhibitor-1 in Human Adipose Tissue , 2005, Circulation.
[5] A. Madan,et al. Insulin enhances vascular endothelial growth factor, interleukin-8, and plasminogen activator inhibitor 1 but not interleukin-6 release by human adipocytes. , 2005, Metabolism: clinical and experimental.
[6] Yihai Cao,et al. Angiogenesis Inhibitor, TNP-470, Prevents Diet-Induced and Genetic Obesity in Mice , 2004, Circulation research.
[7] Hsiu‐Po Wang,et al. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. , 2004, Journal of biomedical science.
[8] A. Madan,et al. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. , 2004, Endocrinology.
[9] U. Smith,et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. , 2004, Obesity research.
[10] H. Kiyama,et al. VEGF mRNA in adipocytes increase with rebound weight-gain after diet-restriction. , 2004, International journal of molecular medicine.
[11] L. Tartaglia,et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.
[12] M. Desai,et al. Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.
[13] Lois E. H. Smith,et al. Adipose tissue growth and regression are regulated by angiopoietin-1. , 2003, Biochemical and biophysical research communications.
[14] E. Benveniste,et al. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells , 2003, Oncogene.
[15] J. Manson,et al. Relationship of total and abdominal adiposity with CRP and IL-6 in women. , 2003, Annals of epidemiology.
[16] R. Jain,et al. Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis , 2003, Circulation research.
[17] H. Bujo,et al. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects , 2003, Diabetologia.
[18] G. Maurer,et al. Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. , 2003, Cardiovascular research.
[19] Chia-Hung Chou,et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway , 2003, Oncogene.
[20] B. Lowell,et al. Adipose tissue mass can be regulated through the vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] V. Vicennati,et al. Hormonal regulation of interleukin-6 production in human adipocytes , 2002, International Journal of Obesity.
[22] T. Issad,et al. Hypoxia increases leptin expression in human PAZ6 adipose cells , 2002, Diabetologia.
[23] K. McCormick,et al. White adipocyte vascular endothelial growth factor: regulation by insulin. , 2002, Endocrinology.
[24] M. Dake,et al. Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. , 2001, Journal of the American College of Cardiology.
[25] M. Dake,et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.
[26] P. Morange,et al. Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. , 2000, Diabetes.
[27] W. Berdel,et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. , 2000, Blood.
[28] J. Soria,et al. Oncostatin M induces angiogenesis in vitro and in vivo. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[29] T. Rosengart,et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. , 1997, The Journal of surgical research.
[30] G. Neufeld,et al. Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor (*) , 1996, The Journal of Biological Chemistry.
[31] B. Spiegelman,et al. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. , 1992, The Journal of biological chemistry.
[32] 星本 さおり. Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects , 2005 .
[33] J. Houštěk,et al. beta-Adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes. , 1997, FEBS letters.